Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Obesity × Pregabalin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Pain, Postoperative 9 Pain 5 Breast Neoplasms 5 Neuralgia 4 Agnosia 4 Neoplasms 2 Head and Neck Neoplasms 2 Chronic Pain 2 Visceral Pain 1 Spinal Cord Neoplasms 1 Seizures 1 Pinealoma 1 Persistent Postoperative Pain 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1 Obesity 1 Neuroectodermal Tumors, Primitive 1 Myotoxicity 1 Meningioma 1 Medulloblastoma 1 Lymphoma, Follicular 1 Lymphoma 1 Liver Neoplasms 1 Leiomyoma 1 Inflammation 1 Hot Flashes 1 Gliosarcoma 1 Glioma 1

Interventions

Exercise 22 Metformin 18 Methods 7 Diet Therapy 7 Diet 7 Tirzepatide 6 Resistance Training 6 Nutrition Assessment 6 Early Intervention, Educational 6 Counseling 6 Caloric Restriction 6 Exenatide 5 Educational Status 4 Docosahexaenoic Acids 4 Diet, Mediterranean 4 semaglutide 3 Vitamin D 3 Therapeutics 3 Standard of Care 3 Liraglutide 3 Dexamethasone 3 Yoga 2 Tablets 2 Surveys and Questionnaires 2 Sugars 2 Specimen Handling 2 Ovidrel 2 Nutritional Status 2 Naltrexone 2 Mindfulness-Based Stress Reduction 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡